Amendment to Schedule 13D Filing for Senti Biosciences, Inc.

This filing is an amendment to a Schedule 13D originally filed on July 15, 2022, by New Enterprise Associates 15, L.P. and related entities. The amendment reports a decrease of over 1% in the beneficial ownership of Senti Biosciences, Inc. Common Stock by the reporting persons. This decrease is attributed to an increase in the total number of outstanding shares of Common Stock. New Enterprise Associates 15, L.P. holds 3,775,615 shares, representing 12.1% of the outstanding shares as of March 19, 2026. The filing also includes an agreement among the reporting persons to file a joint Schedule 13D and a power of attorney authorizing certain individuals to sign on their behalf.